HoldsUp

FoundMyFitness · 2024-07-03 · Rhonda Patrick (host)

The Truth About Alcohol: Risks, Benefits, and Everything In-Between

174 claims checked against research: 8 contradicted 6 overstated 7 needing context 123 supported 30 unverified

6

Overstated

0:43:50Rhonda Patrick (host)overstatedmoderate

In individuals with alcohol use disorder, heavy alcohol consumption causes neuron loss in the hypothalamus, cerebellum, hippocampus, and amygdala.

"In more severe cases, like those seen in individuals with alcohol use disorder, heavy consumption leads to the loss of neurons in several critical brain regions, including the hypothalamus, cerebellum, hippocampus, and amygdala—areas involved in regulating emotions, memory, and spatial navigation." (said at 0:43:50)

Heavy alcohol consumption in individuals with alcohol use disorder is known to cause structural brain damage and regional volume reductions, but the presence of outright neuronal loss varies by brain region. Human neuropathological and post-mortem stereological studies document clear alcohol-related neuronal loss in specific regions, such as the cerebellum (e.g., Purkinje cells) and the hypothalamus (such as the supraoptic and paraventricular nuclei). However, evidence for definitive neuronal loss in the hippocampus and amygdala is conflicting; volume loss in these regions is frequently driven by loss of white matter, glial cell reduction, or dendritic arbor retraction rather than direct neuronal death.

1:10:20Rhonda Patrick (host)overstatedmoderate

Moderate and high doses of alcohol (three or more standard drinks) clearly increase total slow-wave sleep during the night across genders and age groups.

"However, moderate doses of alcohol, or three to four standard drinks, and high doses of alcohol or more, which is more than four standard drinks, clearly increase total slow-wave sleep during the night. This effect is consistent among gender and different age groups." (said at 1:10:20)

A systematic review on acute alcohol ingestion and sleep architecture (Ebrahim et al., 2013) found that while slow-wave sleep (SWS) is consistently increased in the first half of the night across doses, age groups, and genders, an increase in *total night* slow-wave sleep was observed primarily at high doses of alcohol, rather than clearly across both moderate and high doses.

1:22:56Rhonda Patrick (host)overstatedvery low

In vitro and in vivo studies show that extracts from pear, sweet lime, and coconut water enhance the activity of alcohol dehydrogenase and aldehyde dehydrogenase by 20% to 90%.

"Studies conducted in vitro, which is in the lab, and in vivo, which is in living organisms, have shown that fruits such as pear, sweet lime, and coconut water can enhance the activity of these enzymes significantly by about 20 to 90%." (said at 1:22:56)

A 2019 laboratory study (PMID 32914100) tested an anti-hangover formulation containing 65% pear, 25% sweet lime, and 10% coconut water and observed an in vitro increase of 23.31% in alcohol dehydrogenase (ADH) activity and 70.02% in aldehyde dehydrogenase (ALDH) activity in a cell-free enzymatic assay. However, this research was purely in vitro; no in vivo testing in living organisms or humans was conducted to demonstrate this enzyme enhancement.

1:45:40Rhonda Patrick (host)overstatedmoderate

Consuming fewer than 7 drinks per week increases the relative risk for breast cancer by ~4%, colorectal cancer by ~9%, oral and pharyngeal cancer by 13% to 17%, and esophageal cancer and malignant melanoma by 26% to 44%.

"Light drinking, defined as less than an average of seven drinks per week, increases the risk for breast and colorectal cancer by around 4 and 9%, oral and pharyngeal cancer by 13 to 17%, and esophageal and malignant melanoma by 26 to 44%." (said at 1:45:40)

Large meta-analyses of observational studies (most notably Bagnardi and colleagues) confirm that light alcohol consumption (up to 1 drink per day, or ≤7 drinks per week) is associated with statistically significant modest increases in relative risk for several cancers, including female breast cancer (RR ~1.05; 95% CI 1.02–1.08), oral/pharyngeal cancer (RR ~1.17; 95% CI 1.06–1.29), and esophageal squamous cell carcinoma (RR ~1.30; 95% CI 1.09–1.56). However, the claim overstates the risk for other cited cancers: meta-analyses found no statistically significant increased risk of colorectal cancer at light drinking levels (≤1 drink/day), and the pooled relative risk for light drinking and cutaneous melanoma was approximately 10% (RR 1.10; 95% CI 0.96–1.26), which was not statistically significant. The figures of 26% to 44% apply to esophageal cancer or higher intake/unadjusted cohort sub-analyses, not light drinking across melanoma.

2:09:51Rhonda Patrick (host)overstatedmoderate

In the 2020 meta-analysis, alcohol provided no protective effect against cardiovascular disease in participants younger than 40 or those with three or more comorbid conditions such as hypertension, diabetes, and dyslipidemia.

"Furthermore, the study also highlighted that no protective effects were found in individuals with three or more comorbid conditions like high blood pressure, diabetes, and dyslipidemia, nor among participants younger than 40 years old." (said at 2:09:51)

The claim bundles two assertions. The finding regarding age is supported: the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020 systematic analysis showed that for individuals aged 15–39 years (younger than 40), alcohol consumption provides no protective health effect (the theoretical minimum risk exposure level was essentially zero), largely because health loss in this group is dominated by injuries rather than cardiovascular disease. However, the study did not evaluate or report an analysis defining lack of protective effect specifically in individuals having 'three or more comorbid conditions like high blood pressure, diabetes, and dyslipidemia'. Bundling this unsupported comorbid condition threshold with the age finding overstates what the published meta-analysis demonstrated.

2:37:29Rhonda Patrick (host)overstatedlow

Alcohol consumption (both light-to-moderate and high) is associated with a lower risk of erectile dysfunction in men.

"Light to moderate consumption of 14 or fewer drinks, and even high consumption of 14 or more drinks per week, is associated with a lower risk of erectile dysfunction in males." (said at 2:37:29)

Meta-analyses of observational studies show that light-to-moderate alcohol consumption is associated with a decreased risk of erectile dysfunction (ED), but high alcohol consumption is not consistently associated with a statistically significant reduction in risk and demonstrates a non-linear or J-shaped relationship. In a dose-response meta-analysis of 24 observational studies (154,295 participants), light-to-moderate alcohol consumption was associated with reduced ED risk (OR 0.71, 95% CI 0.59–0.86), whereas high consumption (>21 drinks/week) had no significant association (OR 0.99, 95% CI 0.80–1.22). Another meta-analysis of 46 studies noted an odds ratio of 0.82 (95% CI 0.67–1.00) for high consumption and emphasized a J-shaped dose-response curve. Available evidence is observational and largely cross-sectional, which limits causal inference.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.